Search Results - "Kamps, Marius"
-
1
Ex vivo γH2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters
Published in Radiation oncology (London, England) (05-10-2022)“…Abstract Backround Accurate surrogate parameters for radio resistance are warranted for individualized radiotherapy (RT) concepts in prostate cancer (PCa). The…”
Get full text
Journal Article -
2
Implementation of PSMA-PET in focal dose-escalated radiotherapy of primary prostate cancer patients: Results of a planned safety analysis of a phase II trial
Published in Journal of clinical oncology (20-02-2022)“…Abstract only 260 Background: Positron emission tomography targeting prostate specific membrane antigen (PSMA-PET) changes treatment management of primary…”
Get full text
Journal Article -
3
PSMA-PET– and MRI–Based Focal Dose Escalated Radiation Therapy of Primary Prostate Cancer: Planned Safety Analysis of a Nonrandomized 2-Armed Phase 2 Trial (ARO2020-01)
Published in International journal of radiation oncology, biology, physics (01-08-2022)“…The bicentric HypoFocal phase 2 trial investigates the implementation of molecular imaging with positron-emission tomography targeting prostate-specific…”
Get full text
Journal Article -
4
Aquablation versus HoLEP in patients with benign prostatic hyperplasia: a comparative prospective non-randomized study
Published in World journal of urology (09-05-2024)“…Purpose The question of best surgical treatment for lower urinary tract symptoms (LUTS) due to benign prostate hyperplasia (BPH) remains controversial. We…”
Get full text
Journal Article -
5
Ex vivo [gamma]H2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters
Published in Radiation oncology (London, England) (05-10-2022)“…Backround Accurate surrogate parameters for radio resistance are warranted for individualized radiotherapy (RT) concepts in prostate cancer (PCa). The purpose…”
Get full text
Journal Article